Literature DB >> 8175703

X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution.

G P Vigers1, P Caffes, R J Evans, R C Thompson, S P Eisenberg, B J Brandhuber.   

Abstract

Interleukin-1 receptor antagonist (IL-1ra) is a natural competitive antagonist of IL-1. In order to further elucidate the mechanism by which IL-1ra binds without activating the IL-1 receptor, we have solved the crystal structure of IL-1ra at 2.0-A resolution. IL-1ra has the same overall beta-trefoil fold as IL-1 alpha and IL-1 beta and has a very similar hydrophobic core. However, there are a number of structural differences between the molecules, including significant differences at the open end of the beta-barrel, which has been identified in IL-1 beta as a receptor binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175703

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

2.  Self-organizing tree-growing network for the classification of protein sequences.

Authors:  H C Wang; J Dopazo; L G de la Fraga; Y P Zhu; J M Carazo
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

3.  Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state.

Authors:  B S Kendrick; B S Chang; T Arakawa; B Peterson; T W Randolph; M C Manning; J F Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.

Authors:  B S Chang; R M Beauvais; T Arakawa; L O Narhi; A Dong; D I Aparisio; J F Carpenter
Journal:  Biophys J       Date:  1996-12       Impact factor: 4.033

5.  Transport of interleukin-1 across cerebromicrovascular endothelial cells.

Authors:  R A Skinner; R M Gibson; N J Rothwell; E Pinteaux; J I Penny
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

6.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.

Authors:  Andreas Lingel; Thomas M Weiss; Marc Niebuhr; Borlan Pan; Brent A Appleton; Christian Wiesmann; J Fernando Bazan; Wayne J Fairbrother
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

7.  Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.

Authors:  Sampathkumar Krishnan; Andrei A Raibekas
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

8.  Evolutionary divergence and functions of the human interleukin (IL) gene family.

Authors:  Chad Brocker; David Thompson; Akiko Matsumoto; Daniel W Nebert; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2010-10       Impact factor: 4.639

9.  Structural basis for IL-1α recognition by a modified DNA aptamer that specifically inhibits IL-1α signaling.

Authors:  Xiaoming Ren; Amy D Gelinas; Ira von Carlowitz; Nebojsa Janjic; Anna Marie Pyle
Journal:  Nat Commun       Date:  2017-10-09       Impact factor: 14.919

10.  Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Chiara Baggio; Sara Bindoli; Francesca Oliviero; Paolo Sfriso
Journal:  Front Pharmacol       Date:  2018-09-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.